Free screenings will be hosted by Lions SightFirst Eye Hospital, located on Kaptagat Road in Loresho, on the 12th, 13th and 14 November 2026, from 8.00 am to 4.00 pm daily.
As part of its ongoing efforts to raise awareness of Thyroid Disorders and improve access to early diagnosis across Africa, Merck's ThyroAfrica initiative is conducting a pilot screening program in Nairobi, Kenya, aiming to provide Free Screening to 500 people on the 12th, 13th and 14th of November 2026.
The programme will include Thyroid-Stimulating Hormone (TSH) tests and Glycated Haemoglobin (HbA1c) tests for Diabetes detection.
Free screenings will be hosted by Lions SightFirst Eye Hospital, located on Kaptagat Road in Loresho, on the 12th, 13th and 14 November 2026, from 8.00 am to 4.00 pm daily.
Thyroid Disorders: An Under-Recognised Public Health Challenge in Africa
Across African countries, thyroid disorders remain largely invisible within national health priorities and broader non-communicable disease (NCD) strategies.
A lack of reliable data, limited screening and lab coverage & pricing schemes, as well as low awareness among both patients and healthcare providers, contribute to late diagnosis and poor outcomes.
So, Thyroid Disease is often identified at an advanced stage, which increases mortality, treatment costs, and the overall economic burden on families and health systems.
How ThyroAfrica is Driving Change in Thyroid Health
